Revolution Medicines Inc Live Stock Price Today, Share Analysis and Chart

Name: Revolution Medicines Inc: Is Infosys Ltd. worth buying?
Item: Revolution Medicines Inc
Rating: 1.45316675
Author: Trendlyne DVM scores

about

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR si...

40.50 1.55 (3.98%)

35.10% Fall from 52W High

1.7M

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

52.0 / 100

1Yr Price target upside is 81%

14 analysts

Revolution Medicines Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Revolution Medicines Inc Live Stock Price Today, Share Analysis and Chart

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR si...

35.10% Fall from 52W High

SWOT Analysis

Revolution Medicines Inc Live Price Chart